Longevity & Aging
How Much Protein You Really Need to Build Muscle and Age Well
McMaster researcher reveals why current protein recommendations are too low and how resistance training fights aging.
Podcast
Mar 30, 2026 0
Reversing Aging
1509 articles in this topic
Longevity & Aging
Harvard Geneticist George Church on Gene Editing to Eliminate Disease and Reverse Aging
Leading geneticist discusses CRISPR advances, multiplex gene editing, and combination therapies targeting aging mechanisms.
Podcast
Mar 30, 2026 0
Longevity & Aging
Resistance Training Secrets for Maximum Muscle Growth and Longevity Benefits
Dr. Brad Schoenfeld reveals evidence-based strategies for building muscle, bone density, and power throughout life.
Podcast
Mar 30, 2026 0
Longevity & Aging
Blood-Brain Barrier Breakdown Drives Alzheimer's and Dementia Risk
New research reveals how leaky brain blood vessels may be the root cause of cognitive decline, offering fresh prevention strategies.
Podcast
Mar 30, 2026 1
Longevity & Aging
Heat Therapy Boosts Deep Sleep Through Growth Hormone and Brain Temperature Regulation
Saunas and hot baths improve slow wave sleep by triggering immune signals, growth hormone release, and brain thermoregulation pathways.
Podcast
Mar 30, 2026 1
Longevity & Aging
Immutrin Raises $87M to Develop Heart Amyloid Clearing Therapy
UK biotech secures major funding for antibody therapy targeting protein buildup that damages hearts in amyloidosis patients.
Press Release
Mar 30, 2026 0
Longevity & Aging
First Senotherapeutic Drug Shows Promise in Phase 1 Trial for Targeting Aging Cells
Rubedo's RLS-1496 demonstrates early clinical signals in removing senescent cells through GPX4 modulation in human skin tissue.
Press Release
Mar 30, 2026 1
Longevity & Aging
Rubedo's RLS-1496 Shows Promise in Phase 1 Trial for Psoriasis Treatment
Topical therapy RLS-1496 met primary endpoints in Phase 1 trial with no serious adverse events in psoriasis patients.
Press Release
Mar 30, 2026 0
Longevity & Aging
New kidney drug shows 35% improvement in Phase 2 trial for genetic disease
Maze Therapeutics' MZE829 reduced kidney damage markers by over 35% in patients with APOL1-mediated kidney disease in Phase 2 trials.
Press Release
Mar 30, 2026 0
Longevity & Aging
DNA Methylation Clocks Predict Lung Cancer Risk Better Than Standard Models
Epigenetic aging markers outperformed traditional risk assessment tools in predicting lung cancer among smokers.
Research Paper
Mar 30, 2026 0
Longevity & Aging
Epigenetic Aging Clocks Fail to Predict Parkinson's Disease Risk in 19-Year Study
Harvard researchers found that biological aging markers cannot reliably predict who will develop Parkinson's disease or when.
Research Paper
Mar 30, 2026 0
Longevity & Aging
DNA Methylation Clocks Reveal How Fast You're Really Aging
Major review of 435 studies shows DNA methylation patterns can accurately measure biological age beyond chronological years.
Research Paper
Mar 30, 2026 0